# 18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer

> **NCT03824275** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Columbia University** · enrollment: 129 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** 18F- DCFPyL PET/CT

## Key facts

- **NCT ID:** NCT03824275
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-02-12
- **Primary completion:** 2022-12
- **Final completion:** 2023-12
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2022-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03824275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03824275, "18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03824275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*